Lightchain Capital

Recent News

C4-logo-400
September 26, 2022

C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022

READ MORE
wugen-logo-400
September 23, 2022

Wugen to Present at the Upcoming Jefferies Cell & Genetic Medicine Summit

READ MORE
NextRNA-Logo-FullColor-400
September 22, 2022

NextRNA Therapeutics to Participate in Upcoming BioPharm America and Chardan’s 6th Annual Genetic Medicines Conference

READ MORE
wugen-logo-400
September 10, 2022

Wugen Presents Preclinical Data on WU-NK-101 in Solid Tumor Models at the European Society for Medical Oncology (ESMO) Congress 2022

READ MORE
wugen-logo-400
August 25, 2022

Wugen Appoints Natalie Mount, Ph.D., as Chair of the Board of Directors

READ MORE
NextRNA-Logo-FullColor-400
August 11, 2022

NextRNA Therapeutics names Dominique Verhelle as CEO and expands leadership team

READ MORE
CareVet-Logo-New
August 10, 2022

CareVet Offers Bonuses Up to $100,000 for DVMs

READ MORE
C4-logo-400
August 04, 2022

C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

READ MORE
C4-logo-400
August 02, 2022

C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors

READ MORE

Contact Us

Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131

 

LinkedIn

Submit

©2024 LIGHTCHAIN CAPITAL, LLC  All Rights Reserved | Privacy Policy
Website by Tidal Media Group